Quest Diagnostics Incorporated
General ticker "DGX" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $21.2B (TTM average)
Quest Diagnostics Incorporated follows the US Stock Market performance with the rate: 34.4%.
Estimated limits based on current volatility of 1.2%: low 233.42$, high 239.05$
Factors to consider:
- Earnings expected soon, date: 2026-10-22 bmo
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-10-06, amount 0.86$ (Y1.46%)
- Total employees count: 57000 (+1.8%) as of 2025
- Top business risk factors: Cybersecurity threats, Regulatory and compliance, Acquisition/divestiture risks, Labor/talent shortage/retention, Supply chain disruptions
- Earnings for 6 months up through Q2 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [161.76$, 217.37$]
- 2026-12-31 to 2027-12-31 estimated range: [171.46$, 229.52$]
Financial Metrics affecting the DGX estimates:
- Negative: with PPE of 17.8 at the end of fiscal year the price was high
- Positive: 11.29 < Operating profit margin, % of 14.09
- Positive: 8.77 < Operating cash flow per share per price, % of 9.69
- Positive: Industry inventory ratio change (median), % of 0.16 <= 0.47
- Positive: Inventory ratio change, % of -0.19 <= 0
- Positive: 5.14 < Return on assets ratio (scaled to [-100,100]) of 5.83
- Positive: Interest expense per share per price, % of 1.36 <= 1.42
- Positive: -16.84 < Industry operating profit margin (median), % of -16.21
- Positive: -4.49 < Investing cash flow per share per price, % of -3.24
Short-term DGX quotes
Relationship graph
Long-term DGX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $9,252.00MM | $9,871.00MM | $11,047.00MM |
| Operating Expenses | $7,990.00MM | $8,525.00MM | $9,491.00MM |
| Operating Income | $1,262.00MM | $1,346.00MM | $1,556.00MM |
| Non-Operating Income | $-106.00MM | $-171.00MM | $-238.00MM |
| Interest Expense | $152.00MM | $201.00MM | $264.00MM |
| Income(Loss) | $1,156.00MM | $1,175.00MM | $1,318.00MM |
| Taxes | $248.00MM | $273.00MM | $314.00MM |
| Other Income(Loss) | $26.00MM | $19.00MM | $42.00MM |
| Net Income(Loss)* | $854.00MM | $871.00MM | $992.00MM |
| Stockholders Equity | $6,307.00MM | $6,778.00MM | $7,170.00MM |
| Inventory | $190.00MM | $188.00MM | $189.00MM |
| Assets | $14,022.00MM | $16,153.00MM | $16,225.00MM |
| Operating Cash Flow | $1,272.00MM | $1,334.00MM | $1,886.00MM |
| Capital expenditure | $408.00MM | $425.00MM | $527.00MM |
| Investing Cash Flow | $-1,061.00MM | $-2,548.00MM | $-631.00MM |
| Financing Cash Flow | $160.00MM | $1,084.00MM | $-1,388.00MM |
| Earnings Per Share** | $7.62 | $7.85 | $8.94 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.